IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome

Yasin, Shima; Solomon, Krista; Canna, Scott W; Girard, Charlotte; Gabay, Cem; Schiffrin, Eduardo; Sleight, Andrew; Grom, Alexei A; Schulert, Grant S

doi:10.1093/rheumatology/kez284

Scientific article

Case report

English

IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome

ContributorsYasin, Shima; Solomon, Krista; Canna, Scott W; Girard, Charlotte; Gabay, Cem; Schiffrin, Eduardo; Sleight, Andrew; Grom, Alexei A; Schulert, Grant S

Published inRheumatology, vol. 59, no. 2, p. 442-445

Publication date2020

Keywords

Arthritis, Juvenile/complications/drug therapy
Child
Humans
Intercellular Signaling Peptides and Proteins/therapeutic use
Macrophage Activation Syndrome/complications/drug therapy
Male
Recombinant Proteins/therapeutic use
Recurrence
Treatment Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Mécanisme de l'inflammation articulaire (44)

Citation (ISO format)

YASIN, Shima et al. IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome. In: Rheumatology, 2020, vol. 59, n° 2, p. 442–445. doi: 10.1093/rheumatology/kez284

Article (Published version)

Identifiers

PID : unige:138667
DOI : 10.1093/rheumatology/kez284
PMID : 31359055

Commercial URLhttps://academic.oup.com/rheumatology/article/59/2/442/5540360

ISSN of the journal1462-0324

223views

0downloads

Creation20/07/2020 14:33:00

First validation20/07/2020 14:33:00

Update time15/03/2023 22:20:47

Status update15/03/2023 22:20:46

Last indexation02/10/2024 12:28:54

Archive ouverte UNIGE

IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome

Technical informations